Tuesday, May 21, 2019, 12:00 – 1:00PM Eastern (9:00 – 10:00AM Pacific)
Life science enterprises, including CROs, pharmaceutical companies and large academic medical centers are implementing large-scale, advanced quantitative multispectral image analysis. These applications have opened new avenues for cutting-edge research and discovery. As this trend continues to grow in both its scope and impact, the demand on core software functionality to facilitate management, collaboration, and broader translation of multispectral analysis has become an increasingly significant hurdle.
Join Proscia and Akoya Biosciences, two industry-leading multispectral analysis companies, as they share the exciting new ways their platforms address these hurdles and how they impact your high-throughput analysis workflows.
You Will Learn
- How high-throughput tissue analysis workflows can drive your research
- How Proscia simplifies and speeds up your digital pathology workflow
- How Phenoptics enables better spatial biomarker discovery
Nathan Buchbinder
Chief Product Officer
Proscia, Inc.
Daniel Eversole, PhD
Product Manager
Akoya Biosciences, Inc.